Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omegaven in Infants With PNALD
NCT00862446Phase 4Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- Mar 2009
- Primary completion
- Oct 2019
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of eicosapentaenoic acid + docosahexaenoic acid in Parenteral Nutrition Associated Liver Disease (PNALD), sponsored by Vanderbilt University Medical Center. Started Mar 2009; status: completed.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
Parenteral Nutrition Associated Liver Disease (PNALD)
Beyond the preview
Go deeper on NCT00862446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00862446.